Global IVF Services

IVF Services Comprehensive Study by Procedure (Intracytoplasmic Sperm Injection (ICSI-IVF), Non- ICSI-IVF, Intrauterine Insemination), Offering (IVF drugs, IVF media, Reagents, Other), Cycle Type (Fresh IVF Cycles (Non-Donor), Thawed IVF Cycles (Non-Donor), Donor Egg IVF Cycles), End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes) Players and Region - Asia Pacific Market Outlook to 2030

IVF Services Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About IVF Services
Growing cases of infertility among women owing to the change in lifestyle are driving the global IVF services market in the forecasted period. IVF has come up as a dependable procedure to perceive among women. The surge in the success rate of IVF procedure is a vital factor driving the global IVF service market. Along with this, a rise in the trend of delayed pregnancies and High adoption of IVF procedures in both urban and rural areas is driving the growth of the IVF services market globally.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.8%


Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Analyst at AMA Research estimates that Indian Players will contribute the maximum growth to Asia Pacific IVF Services market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bangkok IVF center (Thailand), Bloom Fertility and Healthcare (India), Cloudnine Fertility (India), Fertility Associates (India), Fertility First (Australia), Flinders Reproductive Medicine Pty Ltd (Australia), Genea Oxford Fertility Limited (New Zealand), IVF NAMBA Clinic (Japan), KL Fertility & Gynaecology Centre (Malaysia) and Manipal Fertility (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Monash IVF Wesley Hospital Auchenflower (Australia), Morpheus Life Sciences Pvt. Ltd. (India) and Repromed (Australia).

Segmentation Overview
AMA Research has segmented the market of Asia Pacific IVF Services market by and Region.



On the basis of geography, the market of IVF Services has been segmented into Asia Pacific (China, Japan, New Zealand, India, South Korea, Taiwan, Australia, Thailand, Malaysia, Rest of Asia-Pacific). If we see Market by Procedure, the sub-segment i.e. Intracytoplasmic Sperm Injection (ICSI-IVF) will boost the IVF Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Offering, the sub-segment i.e. IVF drugs will boost the IVF Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cycle Type, the sub-segment i.e. Fresh IVF Cycles (Non-Donor) will boost the IVF Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Fertility Clinics will boost the IVF Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Upsurge in Trend of Delayed Pregnancies and Fuel in IVF Success Rate

Market Growth Drivers:
Growth in Infertility Rate and Rise in Disposable Income Worldwide

Challenges:
Low Awareness Level for IVF in Some under Developed Regions

Restraints:
High Cost Associated With IVF Services and Complications Associated With IVF treatment

Opportunities:
Upsurge in Fertility Tourism and Increase in Number of Fertility Clinics

Market Leaders and their expansionary development strategies
In July 2023, BPEA EQT has acquired 60% of Indira IVF Hospital Pvt. Ltd, India's largest chain of fertility clinics, from TA Associates and the fertility company's founders at a valuation of about USD 1.1 billion, according to two people familiar with the transaction.
In February 2019, Cloudnine Group of Hospitals, India’s leading chain of maternity and childcare and fertility group of hospitals has announced the expansion of its nationwide footprint by launching its dedicated fertility center in Bengaluru at HRBR layout.


Key Target Audience
Medical Research Organizations, Industry Associations, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Procedure
  • Intracytoplasmic Sperm Injection (ICSI-IVF)
  • Non- ICSI-IVF
  • Intrauterine Insemination

By Offering
  • IVF drugs
  • IVF media
  • Reagents
  • Other

By Cycle Type
  • Fresh IVF Cycles (Non-Donor)
  • Thawed IVF Cycles (Non-Donor)
  • Donor Egg IVF Cycles

By End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

By Regions
  • Asia Pacific
    • China
    • Japan
    • New Zealand
    • India
    • South Korea
    • Taiwan
    • Australia
    • Thailand
    • Malaysia
    • Rest of Asia-Pacific
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Infertility Rate
      • 3.2.2. Rise in Disposable Income Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Low Awareness Level for IVF in Some under Developed Regions
    • 3.4. Market Trends
      • 3.4.1. Upsurge in Trend of Delayed Pregnancies
      • 3.4.2. Fuel in IVF Success Rate
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Asia Pacific IVF Services, by Procedure, Offering, Cycle Type, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Asia Pacific IVF Services (Value)
      • 5.2.1. Asia Pacific IVF Services by: Procedure (Value)
        • 5.2.1.1. Intracytoplasmic Sperm Injection (ICSI-IVF)
        • 5.2.1.2. Non- ICSI-IVF
        • 5.2.1.3. Intrauterine Insemination
      • 5.2.2. Asia Pacific IVF Services by: Offering (Value)
        • 5.2.2.1. IVF drugs
        • 5.2.2.2. IVF media
        • 5.2.2.3. Reagents
        • 5.2.2.4. Other
      • 5.2.3. Asia Pacific IVF Services by: Cycle Type (Value)
        • 5.2.3.1. Fresh IVF Cycles (Non-Donor)
        • 5.2.3.2. Thawed IVF Cycles (Non-Donor)
        • 5.2.3.3. Donor Egg IVF Cycles
      • 5.2.4. Asia Pacific IVF Services by: End User (Value)
        • 5.2.4.1. Fertility Clinics
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Surgical Centers
        • 5.2.4.4. Clinical Research Institutes
      • 5.2.5. Asia Pacific IVF Services Region
        • 5.2.5.1. Asia Pacific
          • 5.2.5.1.1. China
          • 5.2.5.1.2. Japan
          • 5.2.5.1.3. New Zealand
          • 5.2.5.1.4. India
          • 5.2.5.1.5. South Korea
          • 5.2.5.1.6. Taiwan
          • 5.2.5.1.7. Australia
          • 5.2.5.1.8. Thailand
          • 5.2.5.1.9. Malaysia
          • 5.2.5.1.10. Rest of Asia-Pacific
    • 5.3. Asia Pacific IVF Services (Price)
  • 6. IVF Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bangkok IVF center (Thailand)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bloom Fertility and Healthcare (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cloudnine Fertility (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Fertility Associates (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fertility First (Australia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Flinders Reproductive Medicine Pty Ltd (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Genea Oxford Fertility Limited (New Zealand)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IVF NAMBA Clinic (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. KL Fertility & Gynaecology Centre (Malaysia)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Manipal Fertility (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Asia Pacific IVF Services Sale, by Procedure, Offering, Cycle Type, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Asia Pacific IVF Services (Value)
      • 7.2.1. Asia Pacific IVF Services by: Procedure (Value)
        • 7.2.1.1. Intracytoplasmic Sperm Injection (ICSI-IVF)
        • 7.2.1.2. Non- ICSI-IVF
        • 7.2.1.3. Intrauterine Insemination
      • 7.2.2. Asia Pacific IVF Services by: Offering (Value)
        • 7.2.2.1. IVF drugs
        • 7.2.2.2. IVF media
        • 7.2.2.3. Reagents
        • 7.2.2.4. Other
      • 7.2.3. Asia Pacific IVF Services by: Cycle Type (Value)
        • 7.2.3.1. Fresh IVF Cycles (Non-Donor)
        • 7.2.3.2. Thawed IVF Cycles (Non-Donor)
        • 7.2.3.3. Donor Egg IVF Cycles
      • 7.2.4. Asia Pacific IVF Services by: End User (Value)
        • 7.2.4.1. Fertility Clinics
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Surgical Centers
        • 7.2.4.4. Clinical Research Institutes
      • 7.2.5. Asia Pacific IVF Services Region
        • 7.2.5.1. Asia Pacific
          • 7.2.5.1.1. China
          • 7.2.5.1.2. Japan
          • 7.2.5.1.3. New Zealand
          • 7.2.5.1.4. India
          • 7.2.5.1.5. South Korea
          • 7.2.5.1.6. Taiwan
          • 7.2.5.1.7. Australia
          • 7.2.5.1.8. Thailand
          • 7.2.5.1.9. Malaysia
          • 7.2.5.1.10. Rest of Asia-Pacific
    • 7.3. Asia Pacific IVF Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. IVF Services: by Procedure(USD Million)
  • Table 2. IVF Services Intracytoplasmic Sperm Injection (ICSI-IVF) , by Region USD Million (2018-2023)
  • Table 3. IVF Services Non- ICSI-IVF , by Region USD Million (2018-2023)
  • Table 4. IVF Services Intrauterine Insemination , by Region USD Million (2018-2023)
  • Table 5. IVF Services: by Offering(USD Million)
  • Table 6. IVF Services IVF drugs , by Region USD Million (2018-2023)
  • Table 7. IVF Services IVF media , by Region USD Million (2018-2023)
  • Table 8. IVF Services Reagents , by Region USD Million (2018-2023)
  • Table 9. IVF Services Other , by Region USD Million (2018-2023)
  • Table 10. IVF Services: by Cycle Type(USD Million)
  • Table 11. IVF Services Fresh IVF Cycles (Non-Donor) , by Region USD Million (2018-2023)
  • Table 12. IVF Services Thawed IVF Cycles (Non-Donor) , by Region USD Million (2018-2023)
  • Table 13. IVF Services Donor Egg IVF Cycles , by Region USD Million (2018-2023)
  • Table 14. IVF Services: by End User(USD Million)
  • Table 15. IVF Services Fertility Clinics , by Region USD Million (2018-2023)
  • Table 16. IVF Services Hospitals , by Region USD Million (2018-2023)
  • Table 17. IVF Services Surgical Centers , by Region USD Million (2018-2023)
  • Table 18. IVF Services Clinical Research Institutes , by Region USD Million (2018-2023)
  • Table 19. Asia Pacific IVF Services, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific IVF Services, by Procedure USD Million (2018-2023)
  • Table 21. Asia Pacific IVF Services, by Offering USD Million (2018-2023)
  • Table 22. Asia Pacific IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 23. Asia Pacific IVF Services, by End User USD Million (2018-2023)
  • Table 24. China IVF Services, by Procedure USD Million (2018-2023)
  • Table 25. China IVF Services, by Offering USD Million (2018-2023)
  • Table 26. China IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 27. China IVF Services, by End User USD Million (2018-2023)
  • Table 28. Japan IVF Services, by Procedure USD Million (2018-2023)
  • Table 29. Japan IVF Services, by Offering USD Million (2018-2023)
  • Table 30. Japan IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 31. Japan IVF Services, by End User USD Million (2018-2023)
  • Table 32. New Zealand IVF Services, by Procedure USD Million (2018-2023)
  • Table 33. New Zealand IVF Services, by Offering USD Million (2018-2023)
  • Table 34. New Zealand IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 35. New Zealand IVF Services, by End User USD Million (2018-2023)
  • Table 36. India IVF Services, by Procedure USD Million (2018-2023)
  • Table 37. India IVF Services, by Offering USD Million (2018-2023)
  • Table 38. India IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 39. India IVF Services, by End User USD Million (2018-2023)
  • Table 40. South Korea IVF Services, by Procedure USD Million (2018-2023)
  • Table 41. South Korea IVF Services, by Offering USD Million (2018-2023)
  • Table 42. South Korea IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 43. South Korea IVF Services, by End User USD Million (2018-2023)
  • Table 44. Taiwan IVF Services, by Procedure USD Million (2018-2023)
  • Table 45. Taiwan IVF Services, by Offering USD Million (2018-2023)
  • Table 46. Taiwan IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 47. Taiwan IVF Services, by End User USD Million (2018-2023)
  • Table 48. Australia IVF Services, by Procedure USD Million (2018-2023)
  • Table 49. Australia IVF Services, by Offering USD Million (2018-2023)
  • Table 50. Australia IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 51. Australia IVF Services, by End User USD Million (2018-2023)
  • Table 52. Thailand IVF Services, by Procedure USD Million (2018-2023)
  • Table 53. Thailand IVF Services, by Offering USD Million (2018-2023)
  • Table 54. Thailand IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 55. Thailand IVF Services, by End User USD Million (2018-2023)
  • Table 56. Malaysia IVF Services, by Procedure USD Million (2018-2023)
  • Table 57. Malaysia IVF Services, by Offering USD Million (2018-2023)
  • Table 58. Malaysia IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 59. Malaysia IVF Services, by End User USD Million (2018-2023)
  • Table 60. Rest of Asia-Pacific IVF Services, by Procedure USD Million (2018-2023)
  • Table 61. Rest of Asia-Pacific IVF Services, by Offering USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific IVF Services, by Cycle Type USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific IVF Services, by End User USD Million (2018-2023)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. IVF Services: by Procedure(USD Million)
  • Table 75. IVF Services Intracytoplasmic Sperm Injection (ICSI-IVF) , by Region USD Million (2025-2030)
  • Table 76. IVF Services Non- ICSI-IVF , by Region USD Million (2025-2030)
  • Table 77. IVF Services Intrauterine Insemination , by Region USD Million (2025-2030)
  • Table 78. IVF Services: by Offering(USD Million)
  • Table 79. IVF Services IVF drugs , by Region USD Million (2025-2030)
  • Table 80. IVF Services IVF media , by Region USD Million (2025-2030)
  • Table 81. IVF Services Reagents , by Region USD Million (2025-2030)
  • Table 82. IVF Services Other , by Region USD Million (2025-2030)
  • Table 83. IVF Services: by Cycle Type(USD Million)
  • Table 84. IVF Services Fresh IVF Cycles (Non-Donor) , by Region USD Million (2025-2030)
  • Table 85. IVF Services Thawed IVF Cycles (Non-Donor) , by Region USD Million (2025-2030)
  • Table 86. IVF Services Donor Egg IVF Cycles , by Region USD Million (2025-2030)
  • Table 87. IVF Services: by End User(USD Million)
  • Table 88. IVF Services Fertility Clinics , by Region USD Million (2025-2030)
  • Table 89. IVF Services Hospitals , by Region USD Million (2025-2030)
  • Table 90. IVF Services Surgical Centers , by Region USD Million (2025-2030)
  • Table 91. IVF Services Clinical Research Institutes , by Region USD Million (2025-2030)
  • Table 92. Asia Pacific IVF Services, by Country USD Million (2025-2030)
  • Table 93. Asia Pacific IVF Services, by Procedure USD Million (2025-2030)
  • Table 94. Asia Pacific IVF Services, by Offering USD Million (2025-2030)
  • Table 95. Asia Pacific IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 96. Asia Pacific IVF Services, by End User USD Million (2025-2030)
  • Table 97. China IVF Services, by Procedure USD Million (2025-2030)
  • Table 98. China IVF Services, by Offering USD Million (2025-2030)
  • Table 99. China IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 100. China IVF Services, by End User USD Million (2025-2030)
  • Table 101. Japan IVF Services, by Procedure USD Million (2025-2030)
  • Table 102. Japan IVF Services, by Offering USD Million (2025-2030)
  • Table 103. Japan IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 104. Japan IVF Services, by End User USD Million (2025-2030)
  • Table 105. New Zealand IVF Services, by Procedure USD Million (2025-2030)
  • Table 106. New Zealand IVF Services, by Offering USD Million (2025-2030)
  • Table 107. New Zealand IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 108. New Zealand IVF Services, by End User USD Million (2025-2030)
  • Table 109. India IVF Services, by Procedure USD Million (2025-2030)
  • Table 110. India IVF Services, by Offering USD Million (2025-2030)
  • Table 111. India IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 112. India IVF Services, by End User USD Million (2025-2030)
  • Table 113. South Korea IVF Services, by Procedure USD Million (2025-2030)
  • Table 114. South Korea IVF Services, by Offering USD Million (2025-2030)
  • Table 115. South Korea IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 116. South Korea IVF Services, by End User USD Million (2025-2030)
  • Table 117. Taiwan IVF Services, by Procedure USD Million (2025-2030)
  • Table 118. Taiwan IVF Services, by Offering USD Million (2025-2030)
  • Table 119. Taiwan IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 120. Taiwan IVF Services, by End User USD Million (2025-2030)
  • Table 121. Australia IVF Services, by Procedure USD Million (2025-2030)
  • Table 122. Australia IVF Services, by Offering USD Million (2025-2030)
  • Table 123. Australia IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 124. Australia IVF Services, by End User USD Million (2025-2030)
  • Table 125. Thailand IVF Services, by Procedure USD Million (2025-2030)
  • Table 126. Thailand IVF Services, by Offering USD Million (2025-2030)
  • Table 127. Thailand IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 128. Thailand IVF Services, by End User USD Million (2025-2030)
  • Table 129. Malaysia IVF Services, by Procedure USD Million (2025-2030)
  • Table 130. Malaysia IVF Services, by Offering USD Million (2025-2030)
  • Table 131. Malaysia IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 132. Malaysia IVF Services, by End User USD Million (2025-2030)
  • Table 133. Rest of Asia-Pacific IVF Services, by Procedure USD Million (2025-2030)
  • Table 134. Rest of Asia-Pacific IVF Services, by Offering USD Million (2025-2030)
  • Table 135. Rest of Asia-Pacific IVF Services, by Cycle Type USD Million (2025-2030)
  • Table 136. Rest of Asia-Pacific IVF Services, by End User USD Million (2025-2030)
  • Table 137. Research Programs/Design for This Report
  • Table 138. Key Data Information from Secondary Sources
  • Table 139. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Asia Pacific IVF Services: by Procedure USD Million (2018-2023)
  • Figure 5. Asia Pacific IVF Services: by Offering USD Million (2018-2023)
  • Figure 6. Asia Pacific IVF Services: by Cycle Type USD Million (2018-2023)
  • Figure 7. Asia Pacific IVF Services: by End User USD Million (2018-2023)
  • Figure 8. Asia Pacific IVF Services Share (%), by Country
  • Figure 9. Asia Pacific IVF Services share by Players 2023 (%)
  • Figure 10. Asia Pacific IVF Services share by Players (Top 3) 2023(%)
  • Figure 11. Asia Pacific IVF Services share by Players (Top 5) 2023(%)
  • Figure 12. BCG Matrix for key Companies
  • Figure 13. Bangkok IVF center (Thailand) Revenue, Net Income and Gross profit
  • Figure 14. Bangkok IVF center (Thailand) Revenue: by Geography 2023
  • Figure 15. Bloom Fertility and Healthcare (India) Revenue, Net Income and Gross profit
  • Figure 16. Bloom Fertility and Healthcare (India) Revenue: by Geography 2023
  • Figure 17. Cloudnine Fertility (India) Revenue, Net Income and Gross profit
  • Figure 18. Cloudnine Fertility (India) Revenue: by Geography 2023
  • Figure 19. Fertility Associates (India) Revenue, Net Income and Gross profit
  • Figure 20. Fertility Associates (India) Revenue: by Geography 2023
  • Figure 21. Fertility First (Australia) Revenue, Net Income and Gross profit
  • Figure 22. Fertility First (Australia) Revenue: by Geography 2023
  • Figure 23. Flinders Reproductive Medicine Pty Ltd (Australia) Revenue, Net Income and Gross profit
  • Figure 24. Flinders Reproductive Medicine Pty Ltd (Australia) Revenue: by Geography 2023
  • Figure 25. Genea Oxford Fertility Limited (New Zealand) Revenue, Net Income and Gross profit
  • Figure 26. Genea Oxford Fertility Limited (New Zealand) Revenue: by Geography 2023
  • Figure 27. IVF NAMBA Clinic (Japan) Revenue, Net Income and Gross profit
  • Figure 28. IVF NAMBA Clinic (Japan) Revenue: by Geography 2023
  • Figure 29. KL Fertility & Gynaecology Centre (Malaysia) Revenue, Net Income and Gross profit
  • Figure 30. KL Fertility & Gynaecology Centre (Malaysia) Revenue: by Geography 2023
  • Figure 31. Manipal Fertility (India) Revenue, Net Income and Gross profit
  • Figure 32. Manipal Fertility (India) Revenue: by Geography 2023
  • Figure 33. Asia Pacific IVF Services: by Procedure USD Million (2025-2030)
  • Figure 34. Asia Pacific IVF Services: by Offering USD Million (2025-2030)
  • Figure 35. Asia Pacific IVF Services: by Cycle Type USD Million (2025-2030)
  • Figure 36. Asia Pacific IVF Services: by End User USD Million (2025-2030)
  • Figure 37. Asia Pacific IVF Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bangkok IVF center (Thailand)
  • Bloom Fertility and Healthcare (India)
  • Cloudnine Fertility (India)
  • Fertility Associates (India)
  • Fertility First (Australia)
  • Flinders Reproductive Medicine Pty Ltd (Australia)
  • Genea Oxford Fertility Limited (New Zealand)
  • IVF NAMBA Clinic (Japan)
  • KL Fertility & Gynaecology Centre (Malaysia)
  • Manipal Fertility (India)
Additional players considered in the study are as follows:
Monash IVF Wesley Hospital Auchenflower (Australia) , Morpheus Life Sciences Pvt. Ltd. (India) , Repromed (Australia)
Select User Access Type

Key Highlights of Report


Mar 2024 220 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global IVF Services Quantitative research analysis
Global IVF Services Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bangkok IVF center (Thailand), Bloom Fertility and Healthcare (India), Cloudnine Fertility (India), Fertility Associates (India), Fertility First (Australia), Flinders Reproductive Medicine Pty Ltd (Australia), Genea Oxford Fertility Limited (New Zealand), IVF NAMBA Clinic (Japan), KL Fertility & Gynaecology Centre (Malaysia) and Manipal Fertility (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Upsurge in Trend of Delayed Pregnancies " is seen as one of major influencing trends for IVF Services Market during projected period 2023-2030.
The IVF Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global IVF Services Report?

Have a Query? Click Here

Other Related Reports

Dental Insurance Services Comprehensive Study by Type (Dental Preferred Provider Organizations (DPPO), Dental Health Maintenance Organizations (DHMO), Dental Indemnity Plans, Others), Application (In...
$ 3650
Neurosyphilis Comprehensive Study by Type (Asymptomatic Neurosyphilis, Meningeal Neurosyphilis, Meningovascular Neurosyphilis, General Paresis, Tabes Dorsalis), Application (Hospital, Clinics, Others...
$ 3800
Cosmetic Dentistry Comprehensive Study by Type (Teeth Whitening, Dental Veneers, Dental Bonding, Dental Implants, Dental Crowns, Inlays & Onlays, Others), Application (Hospitals, Cosmetic Centers, De...
$ 3350
Emergency Telemedicine Services Comprehensive Study by Type (Tele-consultation, Tele-monitoring, Tele-education, Tele-care, Tele-training, Tele-surgery), Disease (Cardiology, Dermatology, Neurology, ...
$ 3800
Nasal Dressing Comprehensive Study by Type (Bioresorbable, Not Absorbable), Application (General Surgery, Otorhinolaryngology, Chronic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Hom...
$ 3350
Healthcare Transportation Services Comprehensive Study by Type (Emergency Transportation, Non-Emergency Transportation), Application (Private Paying Customers, Hospitals, Medical Centers, Nursing Car...
$ 3350